February 8, 2018
Authored and Edited by Nicholas J. Doyle; Sydney R. Kestle; Elizabeth D. Ferrill
In In re Janssen Biotech, Inc., No. 2017-1257 (Fed. Cir. Jan. 23, 2018), the Federal Circuit declined to allow a patent owner to retroactively qualify for the safe-harbor provision of 35 U.S.C. § 121 by attempting to re-designate a particular patent to overcome a double patenting rejection during reexamination.
During prosecution of a parent application, Janssen responded to a restriction requirement by abandoning the parent and filing a continuation-in-part application (CIP). The CIP claimed the benefit of both the abandoned parent and a second application. Twelve years after the CIP issued as a patent, the PTO reexamined the patent on double patenting grounds. In an attempt to trigger § 121’s safe-harbor provision, Janssen cancelled all claims and disclosures not contained in its abandoned parent application. In doing so, Janssen requested that the patent’s benefit claim to the second application be deleted and that the CIP that ripened into the now-challenged patent be re-designated as a divisional application of the abandoned parent. The PTO declined to do so and invalidated the patent for double patenting. Janssen appealed from this decision.
The Federal Circuit declined to apply the safe-harbor provision. The court reasoned Janssen’s choice to file a CIP instead of a divisional in response to a restriction requirement precluded it from qualifying for the safe harbor.
Copyright © 2018 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP.
DISCLAIMER: Although we wish to hear from you, information exchanged in this blog cannot and does not create an attorney-client relationship. Please do not post any information that you consider to be personal or confidential. If you wish for Finnegan, Henderson, Farabow, Garrett & Dunner, LLP to consider representing you, in order to establish an attorney-client relationship you must first enter a written representation agreement with Finnegan. Contact us for additional information. One of our lawyers will be happy to discuss the possibility of representation with you. Additional disclaimer information.
June 10-12, 2024
San Francisco
Lecture
Patent Protection for Software-Related Inventions in Europe and the USA Training Course
June 5, 2024
Hybrid
Workshop
Life Sciences Workshop: Updates and Key Trends in Pharmaceutical and Biotechnology IP Law
May 2, 2024
Cambridge
Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.
We use cookies on this website to provide you with the best user experience. By accepting cookies, you agree to our use of cookies. Please note that if you opt not to accept or if you disable cookies, the “Your Finnegan” feature on this website will be disabled as well. For more information on how we use cookies, please see our Privacy Policy.
Finnegan is thrilled to announce the launch of our new blog, Ad Law Buzz, devoted solely to breaking news, developments, trends, and analysis in advertising law.